NVAX Financial Facts

Revenue: 6.31M
Loss from operations: -33.2M
See Full Income Statement

Accounts receivables: 2.2M
Total assets: 404.63M
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date 2/26/16 *Est. EPS Growth Rate -50.0% *Last Qtr.
Average EPS % Beat Rate -18.9% Revenue Growth Rate -20.4% *Last Qtr.
Average % Move 1-Wk after EPS +4.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/15 Q215 -$0.08-$0.09 +$0.01$14M$9.9M N/A Details
2/26/15 Q414 -$0.13-$0.08 -$0.05N/A$9.6M N/A Details
11/9/15 Q315 -$0.12-$0.09 -$0.03$6.53M$10.59M N/A Details
5/7/15 Q115 -$0.10-$0.11 +$0.01$9.9M$9.7M N/A Details
3/10/14 Q413 -$0.07-$0.08 +$0.01$8.75M$6.22M N/A Details
11/5/14 Q314 -$0.08-$0.07 -$0.01$8.2M$9.2M N/A Details
8/6/14 Q214 -$0.08-$0.07 -$0.01$8.26M$8.74M N/A Details
11/7/13 Q313 N/A-$0.06 N/A N/A$4.56M N/A N/A N/A